Eagle’s Eye View: What is the CV and Renal Impact of Sacubitril/Valsartan Compared to Valsartan in Patients with HF?

In this week’s View, Dr. Eagle looks at a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF that explores sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction. He then covers the potential impact of pulmonary valve replacement in repaired tetralogy of Fallot. Finally, Dr. Eagle discusses a very large study on transcatheter mitral valve repair for degenerative mitral regurgitation.

Twitter Links:

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Acute Coronary Syndromes, Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Geriatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease

Keywords: EaglesEyeView, Heart Failure

< Back to Listings